earnings
confidence high
sentiment neutral
materiality 0.72
Outset Medical Q3 revenue $28.7M, net loss $0.55/share; raises FY2024 revenue guidance to ~$112M
Outset Medical, Inc.
2024-Q3 EPS reported
-$1.98
revenue$84,222,000
- Revenue $28.7M down 6% YoY but up 5% QoQ; product revenue $20.3M down 14% YoY.
- Recurring revenue (cartridges + service) $21M, up 17% YoY; gross margin 34.3% vs 23.6% YoY.
- Net loss $27.9M ($0.55/share) vs $46.2M ($0.93/share) in Q3 2023; non-GAAP net loss $20.2M ($0.39/share).
- FY2024 revenue guidance raised to ~$112M from ~$110M; non-GAAP gross margin guided to mid-30% range.
- Cash & investments $179.0M as of Sept 30, 2024; operating expenses down 36% YoY.